Comparatively, a Japanese study examining 264 eyes found that anti-VEGF injections were associated with better BCVA and smaller SE in children with zone 1 ROP after 4 years of follow-up [46]. The gene discussed is VEGFA; the disease is retinopathy of prematurity.